HomeGRCE • NASDAQ
add
Grace Therapeutics, Inc
Previous close
$3.91
Day range
$3.50 - $4.10
Year range
$1.98 - $4.97
Market cap
35.49M USD
Avg Volume
88.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.83M | 130.93% |
Net income | -3.43M | -4.86% |
Net profit margin | — | — |
Earnings per share | -0.42 | -37.09% |
EBITDA | -4.83M | -131.05% |
Effective tax rate | 19.89% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.17M | -43.83% |
Total assets | 65.35M | -16.44% |
Total liabilities | 9.22M | -19.62% |
Total equity | 56.13M | — |
Shares outstanding | 10.14M | — |
Price to book | 0.71 | — |
Return on assets | -17.88% | — |
Return on capital | -20.91% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.43M | -4.86% |
Cash from operations | -4.24M | -100.62% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | — | — |
Net change in cash | -4.24M | -179.12% |
Free cash flow | -2.61M | -76.88% |
About
Founded
2002
Website
Employees
32
